Vivos Therapeutics, Inc. Defined Contribution Plan, Cost
Vivos Therapeutics, Inc. (VVOS) reported Defined Contribution Plan, Cost of $100.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q/A filed 2022-11-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2022-11-25
- Vivos Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2022-03-31 was $100.00K.
- Vivos Therapeutics, Inc. defined contribution plan, cost for fiscal 2021 was $400.00K, a 33.33% increase from fiscal 2020.
- Vivos Therapeutics, Inc. defined contribution plan, cost for fiscal 2020 was $300.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|
| 2022-03-31 | $100.00K 10-Q/A · filed 2022-11-25 | |
| 2021-12-31 | $400.00K 10-K · filed 2022-03-31 | |
| 2020-12-31 | $300.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |